An interventional study of Resistance exercise and Usual care in Diabetes Mellitus, Type 2, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-11-16.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment
The purpose of this study is to investigate the effect of a 12-week progressive resistance training program on the skeletal muscle function, glycemic control, functional capacity, and quality of life in the elderly with type 2 diabetes mellitus.
9,589 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,332 are open to participants now.
This study's enrollment of 49 is below the median of 81 across 7,713 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →National Taiwan University Hospital is the lead sponsor of 2,608 studies on the registry; 573 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this arm will receive a brochure specific for type 2 diabetes mellitus about the general principles of exercise, nutrition, and diet. They are asked to maintain their activity level.
Behavioral: Usual care
Progressive resistance training, 3 times a week for 12 weeks
Behavioral: Resistance exercise
Progressive resistance exercise training, 3 times a week for 12 weeks.
Participants in this arm will receive a brochure specific for type 2 diabetes mellitus about the general principles of exercise, nutrition, and diet. They are asked to maintain their activity level.
Maximal muscle strength
This outcome measure includes upper and lower body maximal muscle strength.
Time frame: Twelve weeks
Physical body function
This outcome will be assessed by one minute sit-to-stand test and timed "Up and Go" test.
Time frame: Twelve weeks
Quality of life
This outcome measure will be assessed by the diabetes-specific questionnaire.
Time frame: Twelve weeks
Waist circumference
Time frame: Twelve weeks
Body mass index
This outcome measure includes the measurements of body height and body weight.
Time frame: Twelve weeks
Functional capacity
Peak oxygen consumption will be determined by graded exercise test to assess functional capacity.
Time frame: Twelve weeks
Blood biochemical parameters
This outcome measure includes the analysis of fasting glucose, glycated hemoglobin, lipid profile, C-reactive protein, and related metabolites.
Time frame: Twevle weeks
Muscle oxygenation
Muscle oxygenation will be assessed during exercise
Time frame: Twelve weeks
This study is completed, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital →